Persistence of anti-HBs among health care personnel immunized with hepatitis B vaccine.
M T Pasko and
T R Beam, Jr
Infectious Diseases Section, Buffalo VA Medical Center, NY 14215.
Health care personnel who received the hepatitis B vaccine (Heptavax-BR,MSD) were followed for persistence of hepatitis B surface antibody(anti-HBs). Response occurred in 135/146 (92.5 percent) vaccinees.Loss of anti-HBs (less than 72 RIA units; 10 S/N) occurred in35.9 percent during the 36-month surveillance. Stepwise discriminantanalysis found age and magnitude of initial antibody level,but not weight-height index, to be predictive of antibody lossover the 36 months. Twenty-four of 27 employees (88.9 percent)who lost anti-HBs responded to a fourth vaccine dose. In contrast,three of eight initial non-responders (37.5 percent) developedantibody after a fourth vaccine dose.
This article has been cited by other articles:
T. Lincoln, R. W. Tuthill, S. L. DePietro, M. J. Tocco, K. Keough, and T. J. Conklin Viral Hepatitis, Risk Behaviors, Aminotransferase Levels, and Screening Options at a County Correctional Center
Journal of Correctional Health Care,
October 1, 2006;
12(4):
249 - 261.
[Abstract][PDF]
B. J. McMahon, D. L. Bruden, K. M. Petersen, L. R. Bulkow, A. J. Parkinson, O. Nainan, M. Khristova, C. Zanis, H. Peters, and H. S. Margolis Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
Ann Intern Med,
March 1, 2005;
142(5):
333 - 341.
[Abstract][Full Text][PDF]
V. E. Burns, D. Carroll, C. Ring, L. K. Harrison, and M. Drayson Stress, Coping, and Hepatitis B Antibody Status
Psychosom Med,
March 1, 2002;
64(2):
287 - 293.
[Abstract][Full Text]
G. A. Poland, A. Borrud, R. M. Jacobson, K. McDermott, P. C. Wollan, D. Brakke, and J. W. Charboneau Determination of Deltoid Fat Pad Thickness: Implications for Needle Length in Adult Immunization
JAMA,
June 4, 1997;
277(21):
1709 - 1711.
[Abstract][PDF]